MCDERMOTT+ LLC

Lobbying for PATIENTS FOR AFFORDABLE DRUGS NOW · non-partisan national patient organization fighting to lower drug prices

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income · posted Jan 8, 2026

Lobbying activity 3

Health Issues

Issues related to prescription drug competition and pricing.

Consumer Issues/Safety/Products

Issues related to prescription drug competition and pricing.

Medicare/Medicaid

Issues related to prescription drug competition, pricing and pharmacy benefit management reforms.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.